TY - JOUR
T1 - Towards a membrane proteome in Drosophila
T2 - A method for the isolation of plasma membrane
AU - Khanna, Mansi R.
AU - Stanley, Bruce A.
AU - Thomas, Graham H.
N1 - Funding Information:
We thank Drs. Ophelia Papoulas and John Sisson for their expert guidance with the density gradient centrifugation protocol and for the Lava lamp antibody, Dr. Dan Branton for the α-spectrin antibody and Dr. Richard Ordway for the anti-HRP antibody. We thank Dr. B. Tracy Nixon for kindly extending us use of his ultracentrifuge. We thank Anne Stanley for technical assistance with mass spectrometry, Seung-Kyu Lee for helping with fraction collecting, his much-needed support and endless entertainment. We also thank Dr. Kouacou Konan for reagents for the Cytochrome c reductase assay and members of the Thomas Lab for critically reading this manuscript. The anti-Nervana monoclonal antibody, developed by Dr. P.M. Salvaterra, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. This work was funded by American Heart Association Pennsylvania-Delaware Grant-in-Aid #0655501U and by National Science Foundation grant #0644691 to GHT. This paper is dedicated to the memory of John Sisson.
PY - 2010/5/12
Y1 - 2010/5/12
N2 - Background: The plasma membrane (PM) is a compartment of significant interest because cell surface proteins influence the way in which a cell interacts with its neighbours and its extracellular environment. However, PM is hard to isolate because of its low abundance. Aqueous two-phase affinity purification (2PAP), based on PEG/Dextran two-phase fractionation and lectin affinity for PM-derived microsomes, is an emerging method for the isolation of high purity plasma membranes from several vertebrate sources. In contrast, PM isolation techniques in important invertebrate genetic model systems, such as Drosophila melanogaster, have relied upon enrichment by density gradient centrifugation. To facilitate genetic investigation of activities contributing to the content of the PM sub-proteome, we sought to adapt 2PAP to this invertebrate model to provide a robust PM isolation technique for Drosophila.Results: We show that 2PAP alone does not completely remove contaminating endoplasmic reticulum and mitochondrial membrane. However, a novel combination of density gradient centrifugation plus 2PAP results in a robust PM preparation. To demonstrate the utility of this technique we isolated PM from fly heads and successfully identified 432 proteins using MudPIT, of which 37% are integral membrane proteins from all compartments. Of the 432 proteins, 22% have been previously assigned to the PM compartment, and a further 34% are currently unassigned to any compartment and represent candidates for assignment to the PM. The remainder have previous assignments to other compartments.Conclusion: A combination of density gradient centrifugation and 2PAP results in a robust, high purity PM preparation from Drosophila, something neither technique can achieve on its own. This novel preparation should lay the groundwork for the proteomic investigation of the PM in different genetic backgrounds in Drosophila. Our results also identify two key steps in this procedure: The optimization of membrane partitioning in the PEG/Dextran mixture, and careful choice of the correct lectin for the affinity purification step in light of variations in bulk membrane lipid composition and glycosylation patterns respectively. This points the way for further adaptations into other systems.
AB - Background: The plasma membrane (PM) is a compartment of significant interest because cell surface proteins influence the way in which a cell interacts with its neighbours and its extracellular environment. However, PM is hard to isolate because of its low abundance. Aqueous two-phase affinity purification (2PAP), based on PEG/Dextran two-phase fractionation and lectin affinity for PM-derived microsomes, is an emerging method for the isolation of high purity plasma membranes from several vertebrate sources. In contrast, PM isolation techniques in important invertebrate genetic model systems, such as Drosophila melanogaster, have relied upon enrichment by density gradient centrifugation. To facilitate genetic investigation of activities contributing to the content of the PM sub-proteome, we sought to adapt 2PAP to this invertebrate model to provide a robust PM isolation technique for Drosophila.Results: We show that 2PAP alone does not completely remove contaminating endoplasmic reticulum and mitochondrial membrane. However, a novel combination of density gradient centrifugation plus 2PAP results in a robust PM preparation. To demonstrate the utility of this technique we isolated PM from fly heads and successfully identified 432 proteins using MudPIT, of which 37% are integral membrane proteins from all compartments. Of the 432 proteins, 22% have been previously assigned to the PM compartment, and a further 34% are currently unassigned to any compartment and represent candidates for assignment to the PM. The remainder have previous assignments to other compartments.Conclusion: A combination of density gradient centrifugation and 2PAP results in a robust, high purity PM preparation from Drosophila, something neither technique can achieve on its own. This novel preparation should lay the groundwork for the proteomic investigation of the PM in different genetic backgrounds in Drosophila. Our results also identify two key steps in this procedure: The optimization of membrane partitioning in the PEG/Dextran mixture, and careful choice of the correct lectin for the affinity purification step in light of variations in bulk membrane lipid composition and glycosylation patterns respectively. This points the way for further adaptations into other systems.
UR - https://www.scopus.com/pages/publications/77951982956
UR - https://www.scopus.com/pages/publications/77951982956#tab=citedBy
U2 - 10.1186/1471-2164-11-302
DO - 10.1186/1471-2164-11-302
M3 - Article
C2 - 20462449
AN - SCOPUS:77951982956
SN - 1471-2164
VL - 11
JO - BMC genomics
JF - BMC genomics
IS - 1
M1 - 302
ER -